Nephrogenic Systemic Fibrosis (NSF) Links

Nephrogenic Systemic Fibrosis - FDA Gadolinium Report

http://www.fda.gov/bbs/topics/NEWS/2007/NEW01638.html
The U.S. Food and Drug Administration (FDA) has asked manufacturers to include a new boxed warning on the product labeling of all gadolinium-based contrast agents which are used to enhance the quality of magnetic resonance imaging (MRI). The requested gadolinium warning would state that patients with severe kidney insufficiency who receive gadolinium-based agents are at risk for developing a debilitating, and a potentially fatal disease known as nephrogenic systemic fibrosis (NSF). In addition, it would state that patients just before or just after liver transplantation, or those with chronic liver disease, are also at risk for developing nephrogenic systemic fibrosis (NSF) if they are experiencing kidney insufficiency of any severity. "FDA has been carefully monitoring potential safety signals related to these contrast agents after receiving reports about the risk of this potentially life-threatening disease," said Steven Galson, M.D., M.P.H., director of FDA's Center for Drug Evaluation and Research. "This latest action demonstrates FDA's continuing vigilance about ensuring the safety of drug products once they enter the marketplace." Patients with NSF develop thickening of the skin and connective tissues that inhibits their ability to move and may result in broken bones. Other organs are at risk of thickening as well. The cause of nephrogenic systemic fibrosis (NSF) is not known and there is no consistently effective treatment of this condition.

Nephrogenic Fibrosing Dermopathy Research

http://www.icnfdr.org/
Nephrogenic Systematic Fibrosis (NSF) and Nephrogenic Fibrosing Dermopathy (NFD) medical research site.

MRI Contrast Agent Linked to Rare Disease

http://www.docguide.com/news/content.nsf/news/852571020057CCF68525726E006681B9
New research has shown a possible association between a popular magnetic resonance imaging (MRI) contrast agent and the incidence of a rare disease called Nephrogenic Systemic Fibrosis (NSF) in patients with kidney disease.

National Kidney Foundation (NKF)

http://www.kidney.org/kidneyDisease/
Get the facts about kidney disease – learn about early detection, kidney problems, kidney failure, kidney diseases, kidney dialysis and other valuable kidney information.

Nephrogenic Systemic Fibrosis Lawsuit

http://www.mri-gadolinium-lawsuits.com
If you or a loved one had a MRI or a MRA, and a contrast dye or agent was used to enhance the MRI image, and you or a loved developed NFS/NFD, kidney failure or renal failure, then you may be eligible to collect money damages for your injuries and damages. Please fill out our Free Case Evaluation Form to better help us assist you, or call us Toll Free at 1-800-883-9858.



Click Here for a Free Lawsuit
Case Evaluation








* Required Information


Gadolinium Contrast Dyes:

Omniscan
(Gadodiamide)
Manufacturer: GE Healthcare

OptiMARK
(Gadoversetamide Injection)
Manufacturer: Mallinckrodt
Manufacturer: Tyco Healthcare

Magnevist
(Gadopentetate Dimeglumine)
Manufacturer: Bayer HealthCare
Manufacturer: Schering AG
Manufacturer: Berlex

ProHance
(Gadoteridol Injection)
Manufacturer: Bracco Diagnostics

MultiHance
(Gadobenate Dimeglumine)
Manufacturer: Bracco Diagnostics




NFD and NSF Symptoms:

• Skin Swelling
• Skin Hardening
• Skin Tightening
• Orange Peel Textured Skin
• Reddened Skin
• Darkened Skin Patches
• Burning Skin
• Itchy Skin
• Yellow Raised Spots on Eyes
• Bone Problems
• Joint Problems
• Muscle Problems
• Stiff Joints
• Problems Moving Arms
• Problems Moving Hands
• Problems Moving Legs
• Problems Moving Feet
• Problems Straightening Arms
• Problems Straightening Hands
• Problems Straightening Legs
• Problems Straightening Feet
• Deep Pain in Hip Bones
• Deep Pain in Ribs
• Muscle Weakness

High Risk Patients Have:

• Kidney Problems
• Kidney Insufficiency
• Kidney Failure
• Renal Failure
• Had Liver Transplantation
• Chronic Liver Disease